메뉴 건너뛰기




Volumn 60, Issue 4, 2011, Pages 419-424

2009 ESC/ERS pulmonary hypertension guidelines and connective tissue disease

Author keywords

Clinical classification; Connective tissue disease; Evidence based treatment algorithms; Pulmonary arterial hypertension; Pulmonary hypertension

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; IMMUNOSUPPRESSIVE AGENT; PHOSPHODIESTERASE V INHIBITOR; PROSTACYCLIN DERIVATIVE;

EID: 83455230718     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.11-RAI-0362     Document Type: Review
Times cited : (20)

References (29)
  • 1
    • 67649579669 scopus 로고    scopus 로고
    • Updated clinical classification of pulmonary hypertension
    • Simonneau G, Robbins IM, Beghetti M et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54 (Suppl):S43-54.
    • (2009) J Am Coll Cardiol , vol.54 , Issue.SUPPL.
    • Simonneau, G.1    Robbins, I.M.2    Beghetti, M.3
  • 2
    • 70049112901 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)
    • Galiè N, Hoeper MM, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009;30:2493-537.
    • (2009) Eur Heart J , vol.30 , pp. 2493-2537
    • Galiè, N.1    Hoeper, M.M.2    Humbert, M.3
  • 4
    • 70449228209 scopus 로고
    • The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects
    • Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 1958;18:533-47.
    • (1958) Circulation , vol.18 , pp. 533-547
    • Heath, D.1    Edwards, J.E.2
  • 6
    • 0033817459 scopus 로고    scopus 로고
    • Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension
    • The International PPH Consortium
    • The International PPH Consortium. Lane KB, Machado RD et al. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. Nat Genet 2000;26:81-4.
    • (2000) Nat Genet , vol.26 , pp. 81-84
    • Lane, K.B.1    Machado, R.D.2
  • 7
    • 0035797556 scopus 로고    scopus 로고
    • Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia
    • Trembath RC, Thomson JR, Machado RD et al. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2001;345:325-34.
    • (2001) N Engl J Med , vol.345 , pp. 325-334
    • Trembath, R.C.1    Thomson, J.R.2    Machado, R.D.3
  • 8
    • 29144536869 scopus 로고    scopus 로고
    • Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study
    • Hachulla E, Gressin V, Guillevin L et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005;52:3792-800.
    • (2005) Arthritis Rheum , vol.52 , pp. 3792-3800
    • Hachulla, E.1    Gressin, V.2    Guillevin, L.3
  • 9
    • 0142187600 scopus 로고    scopus 로고
    • Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach
    • Mukerjee D, St George D, Coleiro B et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-93.
    • (2003) Ann Rheum Dis , vol.62 , pp. 1088-1093
    • Mukerjee, D.1    St George, D.2    Coleiro, B.3
  • 10
    • 33749329543 scopus 로고    scopus 로고
    • Clinical differences between idiopathic and scleroderma-related pulmonary hypertension
    • Fisher MR, Mathai SC, Champion HC et al. Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006;54:3043-50.
    • (2006) Arthritis Rheum , vol.54 , pp. 3043-3050
    • Fisher, M.R.1    Mathai, S.C.2    Champion, H.C.3
  • 12
    • 0031844681 scopus 로고    scopus 로고
    • Pulmonary vascular disorders in portal hypertension
    • Hervé P, Lebrec D, Brenot F et al. Pulmonary vascular disorders in portal hypertension. Eur Respir J 1998;11: 1153-66.
    • (1998) Eur Respir J , vol.11 , pp. 1153-1166
    • Hervé, P.1    Lebrec, D.2    Brenot, F.3
  • 14
    • 43749107536 scopus 로고    scopus 로고
    • Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome
    • Galie N, Manes A, Palazzini M et al. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome. Drugs 2008;68:1049-66.
    • (2008) Drugs , vol.68 , pp. 1049-1066
    • Galie, N.1    Manes, A.2    Palazzini, M.3
  • 16
    • 0035165175 scopus 로고    scopus 로고
    • Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure
    • Ghio S, Gavazzi A, Campana C et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J AmColl Cardiol 2001;37:183-8.
    • (2001) J AmColl Cardiol , vol.37 , pp. 183-188
    • Ghio, S.1    Gavazzi, A.2    Campana, C.3
  • 17
    • 33645118315 scopus 로고    scopus 로고
    • Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis
    • Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-52.
    • (2006) Chest , vol.129 , pp. 746-752
    • Lettieri, C.J.1    Nathan, S.D.2    Barnett, S.D.3    Ahmad, S.4    Shorr, A.F.5
  • 18
    • 26844449508 scopus 로고    scopus 로고
    • Combined pulmonary fibrosis and emphysema: A distinct underrecognised entity
    • Cottin V, Nunes H, Brillet PY et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005;26:586-93.
    • (2005) Eur Respir J , vol.26 , pp. 586-593
    • Cottin, V.1    Nunes, H.2    Brillet, P.Y.3
  • 19
    • 0026542289 scopus 로고
    • Chronic thromboembolic pulmonary hypertension: Clinical picture and surgical treatment
    • Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992;5: 334-42.
    • (1992) Eur Respir J , vol.5 , pp. 334-342
    • Moser, K.M.1    Auger, W.R.2    Fedullo, P.F.3    Jamieson, S.W.4
  • 20
    • 0021964278 scopus 로고
    • Perfusion lung scanning: Differentiation of primary from thromboembolic pulmonary hypertension
    • Lisbona R, Kreisman H, Novales-Diaz J, Derbekyan V. Perfusion lung scanning: differentiation of primary from thromboembolic pulmonary hypertension. AJR Am J Roentgenol 1985;144:27-30.
    • (1985) AJR Am J Roentgenol , vol.144 , pp. 27-30
    • Lisbona, R.1    Kreisman, H.2    Novales-Diaz, J.3    Derbekyan, V.4
  • 21
    • 0026632785 scopus 로고
    • The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
    • Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
    • (1992) N Engl J Med , vol.327 , pp. 76-81
    • Rich, S.1    Kaufmann, E.2    Levy, P.S.3
  • 22
    • 20544448927 scopus 로고    scopus 로고
    • Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
    • Sitbon O, Humbert M, Jaïs X et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005;111:3105-11.
    • (2005) Circulation , vol.111 , pp. 3105-3111
    • Sitbon, O.1    Humbert, M.2    Jaïs, X.3
  • 23
    • 13844280943 scopus 로고    scopus 로고
    • Survival with first-line bosentan in patients with primary pulmonary hypertension
    • McLaughlin VV, Sitbon O, Badesch DB et al. Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005;25:244-9.
    • (2005) Eur Respir J , vol.25 , pp. 244-249
    • McLaughlin, V.V.1    Sitbon, O.2    Badesch, D.B.3
  • 24
    • 46449124591 scopus 로고    scopus 로고
    • Ambrisentan for the treatment of pulmonary arterial hypertension: Results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2
    • Galiè N, Olschewski H, Oudiz RJ et al. Ambrisentan for the treatment of pulmonary arterial hypertension: results of the ambrisentan in pulmonary arterial hypertension, randomized, double-blind, placebo-controlled, multicenter, efficacy (ARIES) study 1 and 2. Circulation 2008;117: 3010-9.
    • (2008) Circulation , vol.117 , pp. 3010-3019
    • Galiè, N.1    Olschewski, H.2    Oudiz, R.J.3
  • 25
    • 26444534291 scopus 로고    scopus 로고
    • Sildenafil citrate therapy for pulmonary arterial hypertension
    • Galiè N, Ghofrani HA, Torbicki A et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-57.
    • (2005) N Engl J Med , vol.353 , pp. 2148-2157
    • Galiè, N.1    Ghofrani, H.A.2    Torbicki, A.3
  • 26
    • 67649523052 scopus 로고    scopus 로고
    • Tadalafil therapy for pulmonary arterial hypertension
    • Galiè N, Brundage BH, Ghofrani HA et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009; 119:2894-903.
    • (2009) Circulation , vol.119 , pp. 2894-2903
    • Galiè, N.1    Brundage, B.H.2    Ghofrani, H.A.3
  • 27
    • 0036569119 scopus 로고    scopus 로고
    • Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: A randomized, double-blind, placebo-controlled trial
    • Galiè N, Humbert M, Vachiéry JL et al. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2002;39:1496-502.
    • (2002) J Am Coll Cardiol , vol.39 , pp. 1496-1502
    • Galiè, N.1    Humbert, M.2    Vachiéry, J.L.3
  • 28
    • 0030031888 scopus 로고    scopus 로고
    • A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group
    • Barst RJ, Rubin LJ, Long WA et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996;334:296-302.
    • (1996) N Engl J Med , vol.334 , pp. 296-302
    • Barst, R.J.1    Rubin, L.J.2    Long, W.A.3
  • 29
    • 39749156384 scopus 로고    scopus 로고
    • Immunosuppressive therapy in lupus-and mixed connective tissue diseaseassociated pulmonary arterial hypertension: A retrospective analysis of twenty-three cases
    • Jais X, Launay D, Yaici A et al. Immunosuppressive therapy in lupus-and mixed connective tissue diseaseassociated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum 2008; 58:521-31.
    • (2008) Arthritis Rheum , vol.58 , pp. 521-531
    • Jais, X.1    Launay, D.2    Yaici, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.